Lash Group is a leading healthcare consulting and reimbursement services company based in the United States. It was founded in 1989 by Donna and William Lash with the goal of providing comprehensive patient support services to pharmaceutical companies. The company's headquarters is located in Fort Mill, South Carolina.

As a part of AmerisourceBergen Corporation, Lash Group aims to navigate the complexities of the healthcare system to ensure patients have access to life-changing therapies. Its main products and services include patient support programs, reimbursement services, hub services, field reimbursement services, and specialty pharmacy solutions. These offerings help patients and healthcare providers navigate the often-challenging landscape of insurance coverage, appeals, and financial assistance.

Lash Group operates globally and has established a strong presence in the United States, serving numerous pharmaceutical manufacturers, providers, and patients. The company has strategic partnerships and joint ventures with various industry leaders, allowing for a more comprehensive range of services to be provided to clients. In terms of market position, Lash Group is recognized as one of the top healthcare consulting and reimbursement services companies in the United States.

With its extensive expertise in patient support and reimbursement programs, the company has gained a competitive edge over its peers. It maintains a strong foothold in the marketplace by continually evolving and adapting to meet the changing needs of its clients and patients. In recent years, Lash Group has expanded its capabilities and presence through strategic acquisitions and partnerships.

For example, in 2018, the company acquired Dohmen Life Science Services, a leading provider of patient support services. This acquisition further solidified Lash Group's position in the healthcare industry. Currently, Lash Group continues to grow and innovate in the healthcare consulting and reimbursement services space.

By leveraging its expertise, technological advancements, and strategic partnerships, the company aims to enhance patient access to essential therapies and optimize healthcare outcomes